<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-24T21:44:44Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/2455-3492.000020">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/2455-3492.000020</identifier>
									<datestamp>2017-06-10</datestamp>
									<setSpec>PTZ.IJNNN:VOL3</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Synthesis, Characterization and Imaging of Fluorescine Isothiocyanate Conjugated Magnetite Nanoparticles in MCF 7 Breast Cancer Cell Lines
										</dc:title><dc:creator>Mohammad E Khosroshahi</dc:creator><dc:creator>Maral Asemani</dc:creator><dc:description>&lt;p&gt;&lt;span style="font-size:11.0pt;font-family:
&amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:
Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:Gautami;mso-bidi-theme-font:minor-bidi;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA" lang="EN-US"&gt;In this work we
describe fabrication, characterization and possible application of FITC (&lt;/span&gt;&lt;span style="font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:Gautami;
mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA" lang="EN-GB"&gt;fluorescine isothiocyanate&lt;/span&gt;&lt;span style="font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:Gautami;
mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA" lang="EN-US"&gt;) conjugated magnetite nanoparticles (MNPs) for
biomedical applications such as imaging of cancer cells. The MNPs possessed
octahedral-like geometry with almost completely dispersed distribution with
high saturation magnetization. The final FMNPs (&lt;/span&gt;&lt;span style="font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-ascii-theme-font:
minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
mso-hansi-theme-font:minor-latin;mso-bidi-font-family:Gautami;mso-bidi-theme-font:
minor-bidi;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA" lang="EN-GB"&gt;fluorescine isothiocyanate &lt;/span&gt;&lt;span style="font-size:
11.0pt;font-family:&amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;;mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:
minor-latin;mso-bidi-font-family:Gautami;mso-bidi-theme-font:minor-bidi;
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA" lang="EN-US"&gt;magnetite
nanoparticles) absorption band showed 30 nm red shift towards longer wavelength
compared to bare MNP and the laser-induced fluorescence was observed at 518 nm.
The MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) results
showed that FITC conjugation diminishes the toxicity MNPs mainly due to the
reduction of surface charge. Fluorescence microscopy confirmed the uptake and
distribution of FMNPs in MCF 7 (Michigan Cancer Foundation-7) breast cancer
cells, which suggests that it can be utilized for applications such as a
magnetic fluorescent probe for bioassay.&lt;/span&gt;&lt;br&gt;&lt;/p&gt;</dc:description>
										<dc:publisher>International Journal of Nanomaterials, Nanotechnology and Nanomedicine - Peertechz Publications</dc:publisher>
										<dc:date>2017-06-10</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/2455-3492.000020</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Mohammad E Khosroshahi et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
